A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)
Condition(s):Carcinoma, Squamous Cell, Non-small-cell LungLast Updated:February 28, 2024Active, not recruiting